The radiation-induced S-phase checkpoint is independent of CDKN1A

Radiation Research

Volumn 151, Issue 2, 1999, Pages 125-132

  Guo, C Y ^a   D'Anna, J A ^b   Li, R ^a   Larner, J M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; PROTEIN P21;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA REPLICATION ORIGIN; DNA SYNTHESIS INHIBITION; HUMAN; HUMAN CELL; IONIZING RADIATION; KNOCKOUT GENE; PRIORITY JOURNAL; RADIATION RESPONSE;

CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOWN-REGULATION; HUMANS; S PHASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032891922     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579762     Document Type: Article

References (37)

1. L. H. Hartwell and M. B. Kastan, Cell cycle control and cancer. Science 266, 1821-1828 (1994).
2. S. J. Kuerbitz, B. S. Plunkett, W. V. Walsh and M. B. Kastan, Wildtype p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89, 7491-7495 (1992).
3. M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein and R. W. Craig, Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
4. 2 phase checkpoints. Cancer Surveys 29, 151-182 (1997).
5. N. Rhind, B. Furnari and P. Russell, Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev. 11, 504-511 (1997).
6. W. S. el-Deiry, T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler and B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
7. J. W. Harper, G. R. Adami, N. Wei, K. Keyomarsi and S. J. Elledge, The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (1993).
8. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell Biol. 14, 6264-6277 (1994).
9. 1/S-phase and late S-phase checkpoints with regulation of cyclin-dependent kinases in Chinese hamster ovary cells. Radiat. Res. 148, 260-271 (1997).
10. W. G. Nelson and M. B. Kastan, DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell Biol. 14, 1815-1823 (1994).
11. M. Johnson, D. Dimitrov, P. J. Vojta, J. C. Barrett, A. Noda, O. M. Pereira-Smith and J. R. Smith, Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol. Carcinogen. 11, 59-64 (1994).
12. J. W. Harper, S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley and E. Swindell, Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400 (1995).
13. J. M. Larner, H. Lee and J. L. Hamlin, Radiation effects on DNA synthesis in a defined chromosomal replicon. Mol. Cell Biol. 14, 1901-1908 (1994).
14. Y. Wang, M. S. Huq, X. Cheng and G. Iliakis, Regulation of DNA replication in irradiated cells by trans-acting factors. Radiat. Res. 142, 169-175 (1995).
15. 1/S-phase transition in normal human fibroblasts elicited by a heat-labile trans-acting factor in gamma-irradiated HeLa cell extracts. Radiat. Res. 147, 13-21 (1997).
16. 1/S transition in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 94, 526-531 (1997).
17. 1/S and S phase checkpoints. Oncogene 16, 721-736 (1998).
18. S. Waga, G. J. Hannon, D. Beach and B. Stillman, The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578 (1994).
19. Z. Q. Pan, J. T. Reardon, L. Li, H. Flores-Rozas, R. Legerski, A. Sancar and J. Hurwitz, Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J. Biol Chem. 270, 22008-22016 (1995).
20. V. V. Ogryzko, P. Wong and B. H. Howard, WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol. Cell Biol. 17, 4877-4882 (1997).
21. R. B. Painter, Radioresistant DNA synthesis: An intrinsic feature of ataxia telangiectasia. Mutat. Res. 84, 183-190 (1981).
22. M. Artuso, A. Esteve, H. Bresil, M. Vuillaume and J. Hall, The role of the Ataxia telangiectasia gene in the p53, WAF1/CIP1 (p21)-and GADD45-mediated response to DNA damage produced by ionising radiation. Oncogene 11, 1427-1435 (1995).
23. H. Beamish, R. Williams, P. Chen and M. F. Lavin, Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J. Biol. Chem. 271, 20486-20493 (1996).
24. H. Lee, J. M. Larner and J. L. Hamlin, Cloning and characterization of Chinese hamster p53 cDNA. Gene 184, 177-183 (1997).
25. 1 arrest in human cancer cells. Cancer Res. 55, 5187-5190 (1995).
26. P. J. Mosca, P. A. Dijkwel and J. L. Hamlin, The plant amino acid mimosine may inhibit initiation at origins of replication in Chinese hamster cells. Mol Cell Biol. 12, 4375-4383 (1992); Erratum, Mol. Cell Biol. 13, 1981 (1993).
27. P. J. Mosca, P. A. Dijkwel and J. L. Hamlin, The plant amino acid mimosine may inhibit initiation at origins of replication in Chinese hamster cells. Mol Cell Biol. 12, 4375-4383 (1992); Erratum, Mol. Cell Biol. 13, 1981 (1993).
28. H. A. Crissman and J. A. Steinkamp. A new method for rapid and sensitive detection of bromodeoxyuridine in DNA-replicating cells. Exp. Cell Res. 173, 256-261 (1987).
29. D. E. Swartzendruber, Microfluorometric analysis of cellular DNA following incorporation of bromodeoxyuridine. J. Cell Physiol. 90, 445-453 (1977).
30. W. G. McKenna, M. C. Weiss, B. Endlich, C. C. Ling, V. J. Bakanauskas, M. L. Kelsten and R. J. Muschel, Synergistic effect of the v-myc oncogene with H-ras on radioresistance. Cancer Res. 50, 97-102 (1990).
31. R. B. Painter and B. R. Young, Formation of nascent DNA molecules during inhibition of replicon initiation in mammalian cells. Biochim. Biophys. Acta 418, 146-153 (1976).
32. S. Venkatachalam, M. Denissenko and A. A. Wani, Modulation of (+/-)-anti-BPDE mediated p53 accumulation by inhibitors of protein kinase C and poly(ADP-ribose) polymerase. Oncogene 14, 801-809 (1997).
33. E. R. McDonald, G. S. Wu, T. Waldman and W. S. el-Deiry, Repair defect in p21 WAF1/CIP1 -/-human cancer cells. Cancer Res. 56, 2250-2255 (1996).
34. M. Nakanishi, R. S. Robetorye, O. M. Pereira-Smith and J. R. Smith, The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition. J. Biol. Chem. 270, 17060-17063 (1995).
35. F. S. Wyllie, M. F. Haughton, J. A. Bond, J. M. Rowson, C. J. Jones and D. Wynford-Thomas, S phase cell-cycle arrest following DNA damage is independent of the p53/p21 (WAF1) signalling pathway. Oncogene 12, 1077-1082 (1996).
36. R. B. Painter, Inhibition of mammalian cell DNA synthesis by ionizing radiation. Int. J. Radiat. Biol. 49, 771-781 (1986).
37. T. Waldman, Y. Zhang, L. Dillehay, J. Yu, K. Kinzler, B. Vogelstein and J. Williams, Cell-cycle arrest versus cell death in cancer therapy. Nat. Med. 3, 1034-1036 (1997).